TELIX Pharmaceuticals Ltd Free Cash Flow Generation Index
TELIX Pharmaceuticals Ltd free cash flow generation index. TELIX Pharmaceuticals Ltd (TLX) has a Free Cash Flow Generation Index of 0.60x as of June 2025. Free cash flow of AU$16.84 Million represents 1% of operating cash flow (AU$27.98 Million). Check asset resilience ratio of TELIX Pharmaceuticals Ltd to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of TELIX Pharmaceuticals Ltd (2020–2024)
Free cash flow generation index of TELIX Pharmaceuticals Ltd from 2020 to 2024. Historical FCF Generation Index trend for TELIX Pharmaceuticals Ltd across 3 annual periods. Explore TELIX Pharmaceuticals Ltd (TLX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
TELIX Pharmaceuticals Ltd Free Cash Flow Generation Index by Year (2020–2024)
TELIX Pharmaceuticals Ltd free cash flow generation index by year from 2020 to 2024. Year-by-year Free Cash Flow Generation Index for TELIX Pharmaceuticals Ltd. For the full cash flow conversion analysis, see TLX cash generation efficiency.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | AU$9.00 Million | AU$43.03 Million | AU$34.03 Million | ▼ -61.8% |
| 2023 | 0.55x | AU$13.09 Million | AU$23.88 Million | AU$10.79 Million | ▼ -34.4% |
| 2020 | 0.84x | AU$1.64 Million | AU$1.96 Million | AU$322.00K | — |